These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32766184)

  • 1. Case Report: Early Treatment With Chenodeoxycholic Acid in Cerebrotendinous Xanthomatosis Presenting as Neonatal Cholestasis.
    Degrassi I; Amoruso C; Giordano G; Del Puppo M; Mignarri A; Dotti MT; Naturale M; Nebbia G
    Front Pediatr; 2020; 8():382. PubMed ID: 32766184
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment.
    Huidekoper HH; Vaz FM; Verrips A; Bosch AM
    Eur J Pediatr; 2016 Jan; 175(1):143-6. PubMed ID: 26156051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.
    Koyama S; Sekijima Y; Ogura M; Hori M; Matsuki K; Miida T; Harada-Shiba M
    J Atheroscler Thromb; 2021 Sep; 28(9):905-925. PubMed ID: 33967188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrotendinous Xanthomatosis: diversity of presentation and refining treatment with chenodeoxycholic acid.
    Islam M; Hoggard N; Hadjivassiliou M
    Cerebellum Ataxias; 2021 Jan; 8(1):5. PubMed ID: 33509302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of cerebrotendinous xanthomatosis with brain and spinal involvement without tendon xanthomas: Identification of a novel mutation of the CYP27A1 gene.
    Stenos C; Kalafatakis K; Constantoulakis P; Zekiou K; Margoni A; Kardara P; Terentiou A; Stouraitis G; Nikolaou G
    J Clin Lipidol; 2022; 16(3):281-285. PubMed ID: 35428606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective cholestanol screening of cerebrotendinous xanthomatosis among patients with juvenile-onset unexplained bilateral cataracts.
    Fernández-Eulate G; Martin GC; Dureau P; Speeg-Spatz C; Brassier A; Gillard P; Bremond-Gignac D; Thouvenin D; Pagan C; Lamari F; Nadjar Y
    Orphanet J Rare Dis; 2022 Dec; 17(1):434. PubMed ID: 36514115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology and Treatment of Lipid Abnormalities in Cerebrotendinous Xanthomatosis: An Integrative Review.
    Ribeiro RM; Vasconcelos SC; Lima PLGSB; Coelho EF; Oliveira AMN; Gomes EABM; Mota LA; Radtke LS; Carvalho MDS; Araújo DABS; Pinheiro MSN; Gama VCV; Júnior RMM; Braga Neto P; Nóbrega PR
    Brain Sci; 2023 Jun; 13(7):. PubMed ID: 37508912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis.
    Höflinger P; Hauser S; Yutuc E; Hengel H; Griffiths L; Radelfahr F; Howell OW; Wang Y; Connor SL; Duell PB; DeBarber AE; Martus P; Lütjohann D; Griffiths WJ; Schöls L
    J Lipid Res; 2021; 62():100078. PubMed ID: 33891937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
    Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
    Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sterol 27-Hydroxylase Deficiency as a Cause of Neonatal Cholestasis: Report of 2 Cases and Review of the Literature.
    Lipiński P; Klaudel-Dreszler M; Ciara E; Jurkiewicz D; Płoski R; Cielecka-Kuszyk J; Socha P; Jankowska I
    Front Pediatr; 2020; 8():616582. PubMed ID: 33520900
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical report: A patient with a late diagnosis of cerebrotendinous xanthomatosis and a response to treatment.
    Alhariri A; Hamilton K; Oza V; Cordoro K; Sobreira NL; Malloy M; Slavotinek A
    Am J Med Genet A; 2017 Aug; 173(8):2275-2279. PubMed ID: 28590052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.
    Sasamura A; Akazawa S; Haraguchi A; Horie I; Ando T; Abiru N; Takei H; Nittono H; Une M; Kurosawa T; Murai T; Naruse H; Nakayama T; Kotani K; Remaley AT; Kawakami A
    Intern Med; 2018 Jun; 57(11):1611-1616. PubMed ID: 29434128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with Lately Diagnosed Cerebrotendinous Xanthomatosis.
    Yunisova G; Tufekcioglu Z; Dogu O; Bilgic B; Kaleagasi H; Akca Kalem S; Lohmann E; Gurvit HI; Emre M; Hanagasi HA
    Neurodegener Dis; 2019; 19(5-6):218-224. PubMed ID: 32349000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
    Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
    J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A newborn screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios.
    Vaz FM; Bootsma AH; Kulik W; Verrips A; Wevers RA; Schielen PC; DeBarber AE; Huidekoper HH
    J Lipid Res; 2017 May; 58(5):1002-1007. PubMed ID: 28314860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe Neonatal Cholestasis in Cerebrotendinous Xanthomatosis: Genetics, Immunostaining, Mass Spectrometry.
    Gong JY; Setchell KDR; Zhao J; Zhang W; Wolfe B; Lu Y; Lackner K; Knisely AS; Wang NL; Hao CZ; Zhang MH; Wang JS
    J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):561-568. PubMed ID: 28937538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cerebrotendinous xanthomatosis: report of 4 patients].
    Ferrándiz-Pulido C; Bartralot R; Girós M; Bassas P; Heras C; Bodet D; Savall R; García-Patos V
    Actas Dermosifiliogr; 2009 Apr; 100(3):222-6. PubMed ID: 19457308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation in an infant with cerebrotendinous xanthomatosis, cholestasis, and rapid evolution of liver failure.
    Pietrobattista A; Spada M; Candusso M; Boenzi S; Dionisi-Vici C; Francalanci P; Morrone A; Ferri L; Indolfi G; Agolini E; Giordano G; Monti L; Maggiore G; Knisely AS
    Pediatr Transplant; 2022 Sep; 26(6):e14318. PubMed ID: 35633129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal cerebrotendinous xanthomatosis: A case report and literature review.
    Atallah I; Millán DS; Benoît W; Campos-Xavier B; Superti-Furga A; Tran C
    Mol Genet Metab Rep; 2021 Mar; 26():100719. PubMed ID: 33659184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with cerebrotendinous xanthomatosis diagnosed with diverse multisystem involvement.
    Kısa PT; Yildirim GK; Hismi BO; Dorum S; Kusbeci OY; Topak A; Baydan F; Celik FND; Gorukmez O; Gulten ZA; Ekici A; Ozkan S; Yaman A; Arslan N
    Metab Brain Dis; 2021 Aug; 36(6):1201-1211. PubMed ID: 33704661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.